Clinical Trial Update: 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) [EARLY_Phase 1]

View source ↗

Summary

The early Phase 1 trial of 3VM1001 Cream for postherpetic neuralgia has been completed. Sponsor: CDA Research Group, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• 3VM1001 Cream

Snippet

Sponsor: CDA Research Group, Inc. | Conditions: Treatment of PHN | EARLY_Phase 1 | Status: COMPLETED